ECU is involved in research activities which can include clinical trials. ECU has a duty to our insurer, Unimutual, to notify them of ECU's involvement in any clinical trials prior to the clinical trial commencing.
Early notification of clinical trials ensures that insurance protection is afforded to both the University and the researchers during the clinical trial period. Whilst Unimutual provides Medical Malpractice Protection (Medical Treatment Liability) to the University, this cover does not automatically extend to clinical trials. As such, a separate protection must be applied for all “clinical” trials.
The following clinical trial definition is used by Unimutual. The definition helps provide clear understanding and clarity to researchers and support staff as to what constitutes a clinical trial.
A clinical trial is:
A study or research involving humans:
For the purpose of this definition, invasive procedure means any procedure involving:
However, research or study involving humans where the research or study:
Will not be deemed to be a clinical trial.
If you are participating in a clinical trial activity as outlined above and have not advised ECU Insurance, you may be refused insurance cover in the event of a claim.
All research activities that include a clinical trial should undertake a Risk Assessment. As part of the notification process to Risk and Assurance, you must have completed a Risk Assessment. You must email email@example.com and include “Clinical Trial Notification” as the title.
Your email should include the completed Clinical Trial Application form above, any applicable contract and acompleted risk assessment before ECU can submit the information to Unimutual for notification and acceptance. If this has not occurred, insurance cover will not apply for the clinical trial. Please allow up to fifteen (15) working days for the notification to be reviewed and response or confirmation provided.
Please leave a comment about your rating so we can better understand how we might improve the page.